D-0077-2027 Class II Ongoing
FDA drug recall D-0077-2027 was initiated by MACLEODS PHARMA USA, INC on Oct 7, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications. The recall status is ongoing. Affected quantity: 3528 30-count and 216 90-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Oct 7, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3528 30-count and 216 90-count bottles
Product description
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India
Reason for recall
Failed Dissolution Specifications.
Distribution pattern
Nationwide in the USA
Code information
Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0077-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026